Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial. [electronic resource] by
- Tebbutt, N C
- Parry, M M
- Zannino, D
- Strickland, A H
- Van Hazel, G A
- Pavlakis, N
- Ganju, V
- Mellor, D
- Dobrovic, A
- Gebski, V J
Producer: 20130423
In:
British journal of cancer vol. 108
Availability: No items available.
|
|
14.
|
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study. [electronic resource] by
- Steer, C B
- Chrystal, K
- Cheong, K A
- Galani, E
- Marx, G M
- Strickland, A H
- Yip, D
- Lofts, F
- Gallagher, C
- Thomas, H
- Harper, P G
Producer: 20061205
In:
Gynecologic oncology vol. 103
Availability: No items available.
|
|
15.
|
A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer. [electronic resource] by
- Michael, M
- Price, T
- Ngan, S Y
- Ganju, V
- Strickland, A H
- Muller, A
- Khamly, K
- Milner, A D
- Dilulio, J
- Matera, A
- Zalcberg, J R
- Leong, T
Producer: 20090130
In:
British journal of cancer vol. 100
Availability: No items available.
|
|
16.
|
A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma. [electronic resource] by
- Peeters, M
- Strickland, A H
- Lichinitser, M
- Suresh, A V S
- Manikhas, G
- Shapiro, J
- Rogowski, W
- Huang, X
- Wu, B
- Warner, D
- Jain, R
- Tebbutt, N C
Producer: 20130423
In:
British journal of cancer vol. 108
Availability: No items available.
|
|
17.
|
Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies. [electronic resource] by
- Patel, G S
- Jain, K
- Kumar, R
- Strickland, A H
- Pellegrini, L
- Slavotinek, J
- Eaton, M
- McLeay, W
- Price, T
- Ly, M
- Ullah, S
- Koczwara, B
- Kichenadasse, G
- Karapetis, C S
Producer: 20140224
In:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 22
Availability: No items available.
|
|
18.
|
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer. [electronic resource] by
- Eatock, M M
- Tebbutt, N C
- Bampton, C L
- Strickland, A H
- Valladares-Ayerbes, M
- Swieboda-Sadlej, A
- Van Cutsem, E
- Nanayakkara, N
- Sun, Y-N
- Zhong, Z D
- Bass, M B
- Adewoye, A H
- Bodoky, G
Producer: 20130730
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 24
Availability: No items available.
|
|
19.
|
Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. [electronic resource] by
- Tebbutt, N C
- Murphy, F
- Zannino, D
- Wilson, K
- Cummins, M M
- Abdi, E
- Strickland, A H
- Lowenthal, R M
- Marx, G
- Karapetis, C
- Shannon, J
- Goldstein, D
- Nayagam, S S
- Blum, R
- Chantrill, L
- Simes, R J
- Price, T J
Producer: 20111123
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
20.
|
Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer. [electronic resource] by
- Peeters, M
- Price, T J
- Cervantes, A
- Sobrero, A F
- Ducreux, M
- Hotko, Y
- André, T
- Chan, E
- Lordick, F
- Punt, C J A
- Strickland, A H
- Wilson, G
- Ciuleanu, T E
- Roman, L
- Van Cutsem, E
- Tian, Y
- Sidhu, R
Producer: 20140811
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 25
Availability: No items available.
|